Approximately 20% of patients with clinical stage I seminoma relapse. Tumor size and rete testis invasion have been identified as risk factors for relapse. However, the level of evidence supporting ...
A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as a potential predictor of patients at high risk for disease ...
More than half of patients with BRAF-mutated advanced melanoma taking Tafinlar + Mekinist were alive and free of a relapse at 5-years1 Study conclusions are drawn from the largest dataset and longest ...
Please provide your email address to receive an email when new articles are posted on . Circulating tumor cells appeared independently associated with relapse among patients with stage III melanoma, ...
Doctor showing tablet to patient. A new risk stratification model can identify patients with stage I seminoma who have a high risk of relapse, according to researchers. A new risk stratification model ...
An international collaboration has identified therapy-induced, drug-resistance mutations in children with acute lymphoblastic leukemia who relapse. Chemotherapy has helped make the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback